Pituitary tumors: Cell type-specific roles for BMP-4

Molecular and Cellular Endocrinology

Volumn 326, Issue 1-2, 2010, Pages 85-88

  Labeur, Marta ^a   Páez Pereda, Marcelo ^a   Haedo, Mariana ^b   Arzt, Eduardo ^b   Stalla, Günter K ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b INSTITUTO DE FISIOLOGÍA   (Argentina)

Author keywords

ACTH; BMP 4; Pituitary tumors; Prolactin; Retinoic acid; TGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; BROMOCRIPTINE; CORTICOTROPIN; CYCLIC AMP; ESTRADIOL; ESTROGEN; GROWTH HORMONE RELEASING FACTOR; MESSENGER RNA; OCTREOTIDE; PASIREOTIDE; PROLACTIN; RECOMBINANT FOLLITROPIN; SMAD PROTEIN; SOMATOSTATIN DERIVATIVE;

ACTH SECRETING CELL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL TYPE; CUSHING DISEASE; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG POTENTIATION; GENETIC TRANSCRIPTION; GONADOTROPIN SECRETING CELL; GROWTH HORMONE SECRETING ADENOMA; HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; NONHUMAN; PRIORITY JOURNAL; PROLACTIN SECRETING CELL; PROLACTINOMA; SIGNAL TRANSDUCTION;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANIMALS; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEINS; HUMANS; MICE; PITUITARY ACTH HYPERSECRETION; PITUITARY GLAND; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; RATS;

EID: 77955332616     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.04.006     Document Type: Article

References (32)

1. Asa S.L., Kelly M.A., Grandy D.K., Low M.J. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 1999, 140:5348-5355.
2. Asa S.L., Penz G., Kovacs K., Ezrin C. Prolactin cells in the human pituitary. A quantitative immunocytochemical analysis. Arch. Pathol. Lab. Med. 1982, 106:360-363.
3. Derynck R., Akhurst R.J., Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 2001, 29:117-129.
4. Derynck R., Zhang Y., Feng X.H. Smads: transcriptional activators of TGF-beta responses. Cell 1998, 95:737-740.
5. Faure M.O., Nicol L., Fabre S., Fontaine J., Mohoric N., McNeilly A., Taragnat C. BMP-4 inhibits follicle-stimulating hormone secretion in ewe pituitary. J. Endocrinol. 2005, 186:109-121.
6. Gazzerro E., Canalis E. Bone morphogenetic proteins and their antagonists. Rev. Endocr. Metab. Disord. 2006, 7:51-65.
7. Giacomini D., Paez-Pereda M., Stalla J., Stalla G.K., Arzt E. Molecular interaction of BMP-4, TGF-beta, and estrogens in lactotrophs: impact on the PRL promoter. Mol. Endocrinol. 2009, 23:1102-1114.
8. Giacomini D., Paez-Pereda M., Theodoropoulou M., Labeur M., Refojo D., Gerez J., Chervin A., Berner S., Losa M., Buchfelder M., Renner U., Stalla G.K., Arzt E. Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action. Endocrinology 2006, 147:247-256.
9. Heaney A.P., Fernando M., Melmed S. Functional role of estrogen in pituitary tumor pathogenesis. J. Clin. Invest. 2002, 109:277-283.
10. Japon M.A., Rubinstein M., Low M.J. In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development. J. Histochem. Cytochem. 1994, 42:1117-1125.
11. Kahata K., Hayashi M., Asaka M., Hellman U., Kitagawa H., Yanagisawa J., Kato S., Imamura T., Miyazono K. Regulation of transforming growth factor-beta and bone morphogenetic protein signaling by transcriptional coactivator GCN5. Genes Cells 2004, 9:143-151.
12. Kawabata M., Imamura T., Miyazono K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev. 1998, 9:49-61.
13. Kelly M.A., Rubinstein M., Asa S.L., Zhang G., Saez C., Bunzow J.R., Allen R.G., Hnasko R., Ben-Jonathan N., Grandy D.K., Low M.J. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 1997, 19:103-113.
14. Lee K.B., Khivansara V., Santos M.M., Lamba P., Yuen T., Sealfon S.C., Bernard D.J. Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone beta subunit transcription. J. Mol. Endocrinol. 2007, 38:315-330.
15. Lohrer P., Gloddek J., Hopfner U., Losa M., Uhl E., Pagotto U., Stalla G.K., Renner U. Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro. Neuroendocrinology 2001, 74:95-105.
16. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 1998, 67:753-791.
17. Massague J. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 2000, 1:169-178.
18. Massague J., Chen Y.G. Controlling TGF-beta signaling. Genes Dev. 2000, 14:627-644.
19. Miyazono K., Maeda S., Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 2005, 16:251-263.
20. Miyoshi T., Otsuka F., Otani H., Inagaki K., Goto J., Yamashita M., Ogura T., Iwasaki Y., Makino H. Involvement of bone morphogenetic protein-4 in GH regulation by octreotide and bromocriptine in rat pituitary GH3 cells. J. Endocrinol. 2008, 197:159-169.
21. Nudi M., Ouimette J.F., Drouin J. Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity. Mol. Endocrinol. 2005, 19:1329-1342.
22. Onichtchouk D., Chen Y.G., Dosch R., Gawantka V., Delius H., Massague J., Niehrs C. Silencing of TGF-beta signaling by the pseudoreceptor BAMBI. Nature 1999, 401:480-485.
23. Paez-Pereda M., Giacomini D., Refojo D., Nagashima A.C., Hopfner U., Grubler Y., Chervin A., Goldberg V., Goya R., Hentges S.T., Low M.J., Holsboer F., Stalla G.K., Arzt E. Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:1034-1039.
24. Paez-Pereda M., Kovalovsky D., Hopfner U., Theodoropoulou M., Pagotto U., Uhl E., Losa M., Stalla J., Grubler Y., Missale C., Arzt E., Stalla G.K. Retinoic acid prevents experimental Cushing syndrome. J. Clin. Invest. 2001, 108:1123-1131.
25. Rosenfeld M.G., Briata P., Dasen J., Gleiberman A.S., Kioussi C., Lin C.J., O'Connell S.M., Ryan A., Szeto D.P., Treier M. Multistep signaling and transcriptional requirements for pituitary organogenesis in vivo. Recent Prog. Horm. Res. 2000, 55:1-14.
26. Shen E.S., Hardenburg J.L., Meade E.H., Arey B.J., Merchenthaler I., Lopez F.J. Estradiol induces galanin gene expression in the pituitary of the mouse in an estrogen receptor alpha-dependent manner. Endocrinology 1999, 140:2628-2631.
27. Simmons D.M., Voss J.W., Ingraham H.A., Holloway J.M., Broide R.S., Rosenfeld M.G., Swanson L.W. Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev. 1990, 4:695-711.
28. Tsukamoto N., Otsuka F., Miyoshi T., Yamanaka R., Inagaki K., Yamashita M., Otani H., Takeda M., Suzuki J., Ogura T., Iwasaki Y., Makino H. Effects of bone morphogenetic protein (BMP) on adrenocorticotropin production by pituitary corticotrope cells: involvement of up-regulation of BMP receptor signaling by somatostatin analogs. Endocrinology 2010, 151:1129-1141.
29. Vitt U.A., Hsu S.Y., Hsueh A.J. Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules. Mol. Endocrinol. 2001, 15:681-694.
30. Voss J.W., Rosenfeld M.G. Anterior pituitary development: short tales from dwarf mice. Cell 1992, 70:527-530.
31. vsian-Kretchmer O., Hsueh A.J. Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists. Mol. Endocrinol. 2004, 18:1-12.
32. Wrana J.L. Regulation of Smad activity. Cell 2000, 100:189-192.